Federal budget cuts this week have undercut research at the University of Minnesota that was closing in on a better COVID-19 antiviral therapy and first-ever treatments for Ebola and other threatening ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

In her lab, McCourt is working to develop a next-generation antiviral therapy while training – and working alongside – the next generation of scientists, who are currently Niagara undergraduates.

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

CBA therapy of HIV (and possibly other pathogens ... There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

and the potential impact of providing antiviral therapy (antiviral prophylaxis) to mothers during pregnancy. The study estimates for the first time that hepatitis B vertical transmission (passed ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.